Metraipolis › archive › dc_58da51ee423b
Ebselen, a promising host-directed therapeutic option against Yersinia pseudotuberculosis infection — Europe PMC PMID:41756129
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41756129
- DOI
- 10.3389/fmicb.2026.1749626
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T22:18:47.851Z
- SHA-256 of the archived text
6026a56c8726ebb071b226df4603457006a2d2ed3230de5596144ad0aec916a3- Stable URL of this page
https://metraipolis.com/documento/dc_58da51ee423b
How to cite
Ebselen, a promising host-directed therapeutic option against Yersinia pseudotuberculosis infection — Europe PMC PMID:41756129 — Europe PMC (en), https://europepmc.org/article/MED/41756129 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_58da51ee423b (Metraipolis archive dc_58da51ee423b, sha256 6026a56c8726ebb071b226df4603457006a2d2ed3230de5596144ad0aec916a3)
BibTeX
@misc{dc58da51ee423b,
title = {Ebselen, a promising host-directed therapeutic option against Yersinia pseudotuberculosis infection — Europe PMC PMID:41756129},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41756129},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_58da51ee423b; sha256 6026a56c8726ebb071b226df4603457006a2d2ed3230de5596144ad0aec916a3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41756129. Agents can read the archived copy with the MCP tool read_document.